CURTEC ORAL SOLUTION Kenya - English - Pharmacy and Poisons Board

curtec oral solution

bottu s.a laboratories 82 casaurinas street, casablanca, morocco - cetrizine dihydrochloride ph. eur - oral solution - cetrizine dihydrochloride ph. eur - cetirizine

NEALGYL 80MG Tablets Orodispersible Tablet Kenya - English - Pharmacy and Poisons Board

nealgyl 80mg tablets orodispersible tablet

bottu s.a laboratories 82 casaurinas street, casablanca, morocco - phloroglucinol hydrate ph.eur - orodispersible tablet - phloroglucinol hydrate ph.eur 80mg - phloroglucinol

SPIRALIDE® 3 M.I.U, FILM-COATED TABLET Kenya - English - Pharmacy and Poisons Board

spiralide® 3 m.i.u, film-coated tablet

bottus s.a laboratories 82 casaurinas street, casablanca, morocco - spiramycin ph.eur - film-coated tablet - spiramycin ph. eur 3 m.i.u ( 693.10 mg) - spiramycin

Gazyvaro 1000mg40ml concentrate for solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gazyvaro 1000mg40ml concentrate for solution for infusion vials

roche products ltd - obinutuzumab - solution for infusion - 25mg/1ml

Bridgewest LIDOCAINE INJECTION 1% 200 mg/20 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest lidocaine injection 1% 200 mg/20 ml solution for injection ampoule

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Bridgewest LIDOCAINE INJECTION 1% 50 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest lidocaine injection 1% 50 mg/5 ml solution for injection ampoule

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Bridgewest LIDOCAINE INJECTION 2% 400 mg/20 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest lidocaine injection 2% 400 mg/20 ml solution for injection ampoule

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

bridgewest lidocaine injection 2% 100 mg/5 ml solution for injection ampoule

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.

LIDOCAINE HCL 2 % AND EPINEPHRIN 1:100000 Israel - English - Ministry of Health

lidocaine hcl 2 % and epinephrin 1:100000

henry schein shvadent (2009 ) ltd - epinephrine as bitartrate; lidocaine as monohydrate - solution for injection - lidocaine as monohydrate 20 mg/ml; epinephrine as bitartrate 10 mcg/ml - lidocaine - lidocaine - production of local anesthesia by nerve block or infiltration technique.

PINETARSOL BATH OIL tar 2.3% w/w sachet Australia - English - Department of Health (Therapeutic Goods Administration)

pinetarsol bath oil tar 2.3% w/w sachet

ego pharmaceuticals pty ltd - tar, quantity: 23 mg/g - solution - excipient ingredients: solvent green 3; light liquid paraffin; laureth-3; isopropyl myristate; fragrance (perfume) - pinetarsol bath oil is a non-greasy, water dispersible oil for dry skin, with pine tar to relieve severe itching and reduce inflammation. use to relieve the symptoms of eczema, dermatitis, psoriasis and other dry, itchy, inflamed or flaky skin conditions.